Beyond the Device: How SCALPORIN™ R1 Fits into AGF39 Protocols and the CytoMesopecia Concept
SCALPORIN™ R1 Blog Series Part 3 A professional scalp device creates the most ...
Read More
Inside SCALPORIN™ R1: AesMed’s Professional Electroporation Scalp Device for Precision Delivery
SCALPORIN™ R1 Blog Series Part 2 Once the importance of delivery in scalp ...
Read More
Why Delivery Matters in Scalp Care: Electroporation, Active Solutions, and the Logic Behind Professional Treatment
SCALPORIN™ R1 Blog Series Part 1 In professional scalp care, active ingredients often ...
Read More
AesMed Successfully Concludes KIMES 2026 Participation
AesMed is pleased to announce the successful completion of its participation in KIMES ...
Read More
From Conference Posters to Credibility: How SGF57 Built Trust – Series Part 3
In medical aesthetics and hair care, credibility rarely comes from a single moment. ...
Read More
The Clinical Study Behind the Original SGF57 Formula – Series Part 2
In hair care, trust is built when ideas are tested in a way ...
Read More
SGF57: The Original Blueprint Behind AGF39 – Series Part 1
Discover SGF57, the original formula behind AGF39, and how “growth factors + microneedling ...
Read More
AGF39: Clinical Experience, Real-World Data, and Global Adoption- part 4
Blog Series Part 4 Korean Cytokines Mesotherapy for Hair Regrowth – Part 4 ...
Read More
CytoMesopecia – Cytokines Mesotherapy for Alopecia- part 3
Blog Series Part 3 Korean Cytokines Mesotherapy for Hair Regrowth – Part 3 ...
Read More
Why Korea Leads Cytokines Mesotherapy for Hair Regrowth- part 2
Blog Series Part 2 Korean Cytokines Mesotherapy for Hair Regrowth – Part 2 ...
Read More
